COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
COLLEGIUM PHARMACEUTICAL, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$23.01−0.18 (-0.78%)
Close on Oct 19, 2026
- Market cap
- $746.92M
- P/E (TTM)
- 18.6
- Dividend yield
- –
SEC filings
40 of Collegium Pharmaceutical's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 19, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 14, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2025 | Dec 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 19, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 15, 2025 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2025 | Jan 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2024 | Sep 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 28, 2024 | Jul 29, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 24, 2024 | SEC EDGAR |
| Current report | 8-K | May 16, 2024 | May 20, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |